Show simple item record

dc.contributor.author Oleschuk, Curtis en_US
dc.date.accessioned 2007-05-15T19:09:22Z
dc.date.available 2007-05-15T19:09:22Z
dc.date.issued 1998-01-01T00:00:00Z en_US
dc.identifier.uri http://hdl.handle.net/1993/1325
dc.description.abstract Bioreductive agents are an important class of anti-cancer drugs. The role of functional groups in modulating bioreductive drug activation by either DT-diaphorase or NADPH:cytochrome P-450 reductase was studied. 2-(Di(chloroethyl)amino)-1,4-benzoquinone, BM was used as a model bioreductive. Three analogs of BM were studied: 5-methoxy-2-(di(chloroethyl)amino)-1,4-benzoquinone (MBM); 5-chloro-2-(di(chloroethyl)amino)-1,4-benzoquinone (CBM); 6-phenyl-2(di(chloroethyl)amino)-1,4-benzoquinone (PBM). MBM was chosen to illustrate the effect of an electron releasing group, CBM was chosen to illustrate the effect of an electron withdrawing group, while PBM was chosen to illustrate the effect of a sterically bulky group. The cytotoxicities of the BM analogs were measured in H661 cells, human non-small cell lung carcinoma cell line and in SK-MEL-28, a human melanoma cell line, in the presence and absence, of dicoumarol, an inhibitor of DT-diaphorase. The role of a methoxy group in reversing the effect of DT-diaphorase on the cytotoxic activity of BM and MBM was studied. (Abstract shortened by UMI.) en_US
dc.format.extent 7101148 bytes
dc.format.extent 184 bytes
dc.format.mimetype application/pdf
dc.format.mimetype text/plain
dc.language en en_US
dc.language.iso en_US
dc.rights info:eu-repo/semantics/openAccess
dc.title Structure-activity studies of bioreductive anti-cancer agents en_US
dc.type info:eu-repo/semantics/masterThesis
dc.degree.discipline Pharmacology & Therapeutics en_US
dc.degree.level Master of Science (M.Sc.) en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

View Statistics